19-10514445-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_030760.5(S1PR5):c.567C>T(p.Tyr189=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00275 in 1,609,504 control chromosomes in the GnomAD database, including 94 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 47 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 47 hom. )
Consequence
S1PR5
NM_030760.5 synonymous
NM_030760.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.47
Genes affected
S1PR5 (HGNC:14299): (sphingosine-1-phosphate receptor 5) The lysosphingolipid sphingosine 1-phosphate (S1P) regulates cell proliferation, apoptosis, motility, and neurite retraction. Its actions may be both intracellular as a second messenger and extracellular as a receptor ligand. S1P and the structurally related lysolipid mediator lysophosphatidic acid (LPA) signal cells through a set of G protein-coupled receptors known as EDG receptors. Some EDG receptors (e.g., EDG1; MIM 601974) are S1P receptors; others (e.g., EDG2; MIM 602282) are LPA receptors.[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 19-10514445-G-A is Benign according to our data. Variant chr19-10514445-G-A is described in ClinVar as [Benign]. Clinvar id is 769957.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.47 with no splicing effect.
BA1
GnomAdExome4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0511 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
S1PR5 | NM_030760.5 | c.567C>T | p.Tyr189= | synonymous_variant | 2/2 | ENST00000333430.6 | |
S1PR5 | NM_001166215.2 | c.567C>T | p.Tyr189= | synonymous_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
S1PR5 | ENST00000333430.6 | c.567C>T | p.Tyr189= | synonymous_variant | 2/2 | 1 | NM_030760.5 | P1 | |
S1PR5 | ENST00000439028.3 | c.567C>T | p.Tyr189= | synonymous_variant | 2/2 | 2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0144 AC: 2195AN: 152210Hom.: 47 Cov.: 33
GnomAD3 genomes
AF:
AC:
2195
AN:
152210
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00381 AC: 908AN: 238048Hom.: 13 AF XY: 0.00287 AC XY: 372AN XY: 129784
GnomAD3 exomes
AF:
AC:
908
AN:
238048
Hom.:
AF XY:
AC XY:
372
AN XY:
129784
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00154 AC: 2238AN: 1457180Hom.: 47 Cov.: 37 AF XY: 0.00132 AC XY: 956AN XY: 724490
GnomAD4 exome
AF:
AC:
2238
AN:
1457180
Hom.:
Cov.:
37
AF XY:
AC XY:
956
AN XY:
724490
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0144 AC: 2192AN: 152324Hom.: 47 Cov.: 33 AF XY: 0.0140 AC XY: 1040AN XY: 74482
GnomAD4 genome
AF:
AC:
2192
AN:
152324
Hom.:
Cov.:
33
AF XY:
AC XY:
1040
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3472
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 14, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at